Venture Capital & Emerging Growth

• Represented CleanSlate Centers, Inc. in its Series B preferred stock financing led by Apple Tree Partners IV, L.P. CleanSlate operates drug addiction treatment and rehabilitation centers throughout Massachusetts, Pennsylvania, and Indiana
• Represented Clinify Health Inc., a digital health company, in its initial Series Seed round
• Represented Codoxo, Inc., an artificial-intelligence (AI)-assisted platform designed to accelerate the identification of fraud, waste, and abuse in healthcare plans, in its Series B financing
• Represented Curation Health, LLC, a portfolio company of WindRose Health Investors, LLC, in its Series A financing round with Deerfield Management Company, LP
• Represented DropStat, Inc., a nurse scheduling solution, in multiple follow-on rounds
• Represented Equum Medical in its growth equity investment from The Heritage Group
• Represented Eurazeo’s Nov Santé Actions Non Cotées Fund in its first growth equity deal in Kinvent Physio, which amounted to €16 million
• Represented Five Arrows Growth Capital in a new round of financing for Padoa, which amounted to €80 million
• Represented Florence Healthcare, Inc. in its Series C financing
• Represented Gradient Denervation Technologies, a medical device company developing a minimally invasive solution for the treatment of heart failure in patients with pulmonary hypertension, in its Series A financing led by Sabadell Asabys II and Sofinnova Partners
• Represented Maven Clinic, the largest virtual clinic for women’s and family health, in its Series E funding round led by General Catalyst
• Represented Pediatrix Medical Group, Inc. (formerly, Mednax), a Florida-based healthcare organization, in its Series B investment in BraveCare, Inc., a pediatric healthcare organization
• Represented Nightingale Veterinary, a veterinary medicine platform, in multiple financing transactions
• Represented PreciseDx, Inc., a healthcare services provider delivering patient-specific insights through AI-driven pathology tests and labs, in its Series B financing led by Eventide, Inc.
• Represented Summus Global, a company that connects individuals, families, and doctors with the right specialist, in multiple financing transactions
• Represented White Plains Hospital in multiple investments

Fund Representation

• Represented BIP Ventures in financing multiple investments
• Represented CVS Health Ventures, a corporate venture capital fund, in connection with its investment in Carbon Health, a primary and urgent care company
• Represented Deerfield Management Company and its affiliated funds as the lead investors in their Series A preferred stock financing of Hometeam Technologies, Inc., an emerging healthcare technology company that leverages its proprietary platform to enhance in-home caregiver services
• Represented Deerfield Management Company in its Series C investment round in Presidio Medical
• Represented Enhanced Healthcare Partners in its Series B and C capital raises in Vytalize Health, Inc., a value-based care platform providing smart technology and a virtual clinic that enables independent physicians and practices to succeed in value-based care arrangements
• Represented General Atlantic in its Series B funding in Javara, a leading integrated research organization and a pioneer of clinical research as a care option
• Represented General Atlantic as healthcare regulatory counsel in its Series D financing of Vida Health, a virtual chronic mental and physical care platform
• Represented General Atlantic as healthcare regulatory counsel in its Series D financing of Doctor on Demand, Inc., a leading virtual healthcare provider
• Represented McKesson Ventures in multiple investments, including in IVXpress, Inc. and Shyft
• Represented Merck Global Health Innovation Fund, LLC in multiple investments, including in Delfi Diagnostics, Octave, M2GEN, and PreciseDx
• Represented Morgan Health in its Series C-3 investment in Kindbody, Inc.
• Represented Morgan Health in its Series D-2 investment in Paulus Holdings Limited (d/b/a LetsGetChecked)
• Represented Morgan Health in its Series B-1 investment in Centivo
• Represented The Carlyle Group in its investment round in Grand Rounds, a leader in healthcare quality and clinical navigation
• Represented Triatomic Capital in multiple investments, including in Chemify, Betteromics, Elegen, and d-Matrix
• Represented Warburg Pincus LLC as regulatory counsel in connection with its Series C leading investment in Aetion

Technology and SaaS

Company Representation

• Represented Ardian, in its acquisition of a minority stake in Taxually
• Represented Cove Tool, Inc., a web-based software for analyzing, drawing, engineering, and connecting data for building design and construction, in its Series B financing
• Represented ClassPass, a premier fitness membership, in each of its equity financings, including its $285 million Series E financing; its acquisitions of Clickypass, fitmob, FitnessCollection, GuavaPass, and MuvPass; and its merger with Mindbody, Inc. and the companion $500 million equity financing for the combined company*
• Represented CyEx in its acquisition of Simpluris, the industry leader in class action settlement administration for the public sector across various verticals
• Represented a leading cleantech solutions company in its late-stage financing rounds and multiple acquisitions*
• Represented Maximum Effort Marketing in its sale to performance television platform MNTN*
• Represented several high-profile talent and other high-profile individual investors in their venture investments
• Represented Olympus Pines in various financing and transactional matters
• Represented Optios, Inc. in its initial equity financing round
• Represented Texture in its financing rounds*
• Represented The Hershey Company in various growth company investments*
• Represented Riot Security in its Series A financing round led by Base10, which amounted to $14 million
• Represented 9dcc in its seed financing*

Fund Representation

• Represented BIP Ventures in multiple investments
• Represented Hoxton Ventures LLP, an early-stage venture capital firm, as lead investor in its Series Seed fundraising round for Poetics AI Limited, a provider of AI-powered solutions to the creative sector to accelerate and improve generation and analysis of long-form text through software as a service (SaaS)
• Represented Knoll Ventures in multiple investments
• Represented Motorola Solutions, Inc. in multiple corporate venture capital investments in various software and technology companies
• Represented SineWave Ventures in the formation of its venture funds and in all of its 30+ investments and portfolio exits
• Represented Viking Global Investors in multiple investments, including in Arctic Wolf, Clip, and Affinivax, Inc.

Life Sciences and Biotech

Company Representation

• Represented Aboleris Pharma, a Belgian biopharmaceutical company developing an entirely novel approach to the treatment of chronic autoimmune and inflammatory diseases, in its Series A financing
• Represented Antabio in raising Series B funding for the development of new treatments for antibiotic-resistant infections
• Represented BioSpring in its investment in Abzena, a leading global partnership research organization providing integrated discovery, development, and manufacturing of biologics and antibody drug conjugates
• Represented Cleveland Clinic, a nonprofit multispecialty academic medical center, in its Series B equity financing of Centerline Biomedical, Inc., a private medical technology company that develops surgical navigation systems
• Represented Cordis in multiple investments, including in Portola, Ladera, Medical, Echo Medical, Venice Medical, Tahoe Medical, IV-X Health, and Convext Medical
• Represented Corteria Pharmaceuticals, a biopharmaceutical company specializing in the development of transformative therapies for unaddressed heart failure subpopulations, in its €65 million Series A round transaction
• Represented DioGenX, a biotech company specializing in the regeneration of insulin-producing beta cells for the treatment of diabetes, in its Series A financing round
• Represented ImmuneSensor Therapeutics, Inc., a clinical-stage biotechnology company, in connection with an investment by Yunnan Baiyao Group Co., Ltd. for Series A preferred stock in ImmuneSensor
• Represented Kythera Labs, Inc., a data analytics provider in the pharma services space, in a follow-on investment
• Represented Merck KGaA, Darmstadt, Germany, a leading science and technology company, in its venture-capital-style investment in High Line Bio, Inc. (HLB)
• Represented Novo Holdings A/S, an investment and holdings company, in its Series C investment in Amolyt Pharma, a global company that develops therapeutic peptides for rare endocrine and related diseases, led by Sofinnova Partners
• Represented TRiCares GmbH, a pioneer in the minimally invasive treatment of tricuspid regurgitation, in its €47 million financing round following the closing of its Series C financing round
• Represented Toku Inc., a leader in applying AI-powered diagnostic and screening tools to retinal imaging, in its Series A preferred financing round

Fund Representation

• Represented Advent Life Sciences, a UK-based venture capital fund, in its investment in the Series C financing of Moximed, Inc., a California-based developer of shock absorbing knee implants for osteoarthritis
• Represented Affinity Partners, LLC in its Series A investment in Altesa BioSciences, Inc., a clinical-stage biopharmaceutical company
• Represented Aisling Capital in multiple investments, including in TheRas,Inc., CalciMedica, Bicara Therapeutics, Mindful Health Solutions, and Treeline Biosciences
• Represented Ajax Health in multiple investments, including in Cortex, Maverix Medical, LLC, and Treeline Biosciences
• Represented Amzak Health in multiple investments, including in KOKO Medical
• Represented Deerfield Management in multiple investments, including in Adaptive Phage Therapeutics, Adela, Pleno Inc., Beartooth, Medical Microinstruments, Inc., and Presidio Medical, Inc.
• Represented General Atlantic in multiple investments, including in Javara, Motif FoodWorks and Ultima Genomics, Inc.
• Represented Merck Global Health Innovation Fund in connection with various life sciences investments
• Represented Norwest Venture Partners, a California-based venture capital firm, as an investor in the closing of its Series E investment round in Elligo Health Research, Inc., a clinical trial technology company
• Represented Novartis Venture Fund, Lilly Ventures, and Enso Ventures in their investment in Cavion, Inc.
• Represented Novo Holdings in its Series C financing of Amolyt Pharma
• Represented Sofinnova Partners in its investments in Cure51, LifeX, and Hitachi, Ltd.
• Represented The Clermont Group, a Singapore-based international business group, as the lead investor in its Series A investment round in PostEra, a Boston-based biotechnology company

Insurtech

Company Representation

• Represented Boost Insurance in its formation and various transactional and regulatory matters*
• Represented CHAMP Titles in its $18 million Series C funding led by Point72 Ventures
• Represented Pathpoint, Inc., a digital insurance wholesale brokerage service provider, in its capital raise with investor Caffeinated Capital
• Represented Rhino Labs, Inc. in its formation and Series Seed preferred stock initial capital raise of $1.5 million with a prominent venture capital firm*
• Represented Tarmika, Inc., a commercial lines rating solution for small business insurance, in its acquisition by Applied Systems, a global provider of cloud-based software that powers the business of insurance
• Represented weSure Digital Insurance Services, Inc. in its investments from Technology Insurance Company Inc.

Fund Representation

• Represented a New-York-based fund as lead investor in its Series C financing and subsequent follow-on round for an insurtech company whose nationally available products integrate the procurement of homeowner’s insurance directly into the home-buying process
• Represented a Swiss family office in its Series B investment in a digital insurance producer that empowers consumers to buy home and auto insurance on their smartphones, tablets, or computers in minutes
• Represented Gigafund, a venture capital firm, in its follow-on investment in Sana Benefits’ $20 million Series A extension funding
• Represented IA Capital Group in certain startup venture investments
• Represented Infinity VC in its Series A investment in Sensible Weather
• Represented a venture capital firm in its investment in a tech-enabled managing general agent specializing in wildfire-related risks
• Represented Volery Capital Partners as lead investor in its Series B funding of Buckle, a digital financial services company
• Represented USAA in its acquisition of Noblr, Inc., a usage-based insurance business

FinTech

Company Representation

• Represented Trustpair in its €20 million Series B financing round led by Tikehau Ace Capital and Tikehau’s historical shareholders, including Breega and Axeleo Capital

Fund Representation

• Represented HSBC Financial Technology Venture Capital Fund in its cross-border convertible note investment in BetterTradeOff Pte Ltd., a Singapore-based fintech company
• Represented Multicoin Capital, a thesis-driven investment firm that invests in cryptocurrencies, tokens, and blockchain companies, in the formation of Venture Fund III
• Represented WestCap in leading a $1 billion funding round for New York Digital Investment Group LLC, a top Bitcoin company. This funding will value the company at more than $7 billion

*Matter handled prior to joining McDermott

Show Less